121 related articles for article (PubMed ID: 38131342)
21. Surveillance of screening-detected cancers (colon and rectum, breast, and cervix) - United States, 2004-2006.
Henley SJ; King JB; German RR; Richardson LC; Plescia M;
MMWR Surveill Summ; 2010 Nov; 59(9):1-25. PubMed ID: 21102407
[TBL] [Abstract][Full Text] [Related]
22. Coding completeness and quality of relative survival-related variables in the National Program of Cancer Registries Cancer Surveillance System, 1995-2008.
Wilson RJ; O'Neil ME; Ntekop E; Zhang K; Ren Y
J Registry Manag; 2014; 41(2):65-71; quiz 96-7. PubMed ID: 25153011
[TBL] [Abstract][Full Text] [Related]
23. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment.
Edwards BK; Brown ML; Wingo PA; Howe HL; Ward E; Ries LA; Schrag D; Jamison PM; Jemal A; Wu XC; Friedman C; Harlan L; Warren J; Anderson RN; Pickle LW
J Natl Cancer Inst; 2005 Oct; 97(19):1407-27. PubMed ID: 16204691
[TBL] [Abstract][Full Text] [Related]
24. How representative are the surveillance, epidemiology, and end results (SEER) program cancer data of the United States?
Merrill RM; Dearden KA
Cancer Causes Control; 2004 Dec; 15(10):1027-34. PubMed ID: 15801487
[TBL] [Abstract][Full Text] [Related]
25. Decline in breast cancer incidence--United States, 1999-2003.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2007 Jun; 56(22):549-53. PubMed ID: 17557070
[TBL] [Abstract][Full Text] [Related]
26. Plasma Cell Myeloma - 20-Year Comparative Survival and Mortality of Three Plasma Cell Myeloma ICD-O-3 Oncologic Phenotypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 111,041 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4).
Milano AF
J Insur Med; 2018; 47(4):203-211. PubMed ID: 30668210
[TBL] [Abstract][Full Text] [Related]
27. Invasive cancer incidence - United States, 2009.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2013 Feb; 62(7):113-8. PubMed ID: 23425959
[TBL] [Abstract][Full Text] [Related]
28. Thyroid cancer incidence patterns in Sao Paulo, Brazil, and the U.S. SEER program, 1997-2008.
Veiga LH; Neta G; Aschebrook-Kilfoy B; Ron E; Devesa SS
Thyroid; 2013 Jun; 23(6):748-57. PubMed ID: 23410185
[TBL] [Abstract][Full Text] [Related]
29. Examining colorectal cancer survivors' surveillance patterns and experiences of care: a SEER-CAHPS study.
Mollica MA; Enewold LR; Lines LM; Halpern MT; Schumacher JR; Hays RD; Gibson JT; Schussler N; Kent EE
Cancer Causes Control; 2017 Oct; 28(10):1133-1141. PubMed ID: 28866818
[TBL] [Abstract][Full Text] [Related]
30. Distinct breast cancer incidence and prognostic patterns in the NCI's SEER program: suggesting a possible link between etiology and outcome.
Anderson WF; Jatoi I; Devesa SS
Breast Cancer Res Treat; 2005 Mar; 90(2):127-37. PubMed ID: 15803359
[TBL] [Abstract][Full Text] [Related]
31. Use of imputed population-based cancer registry data as a method of accounting for missing information: application to estrogen receptor status for breast cancer.
Howlader N; Noone AM; Yu M; Cronin KA
Am J Epidemiol; 2012 Aug; 176(4):347-56. PubMed ID: 22842721
[TBL] [Abstract][Full Text] [Related]
32. Outcome Expectancies, Health Information Seeking, and Cancer Beliefs Associated with Multivitamin/Mineral Use in a National Sample, HINTS-FDA 2015.
Knippen KL; Mahas R; Van Wasshenova E
J Acad Nutr Diet; 2020 Aug; 120(8):1368-1376. PubMed ID: 32061553
[TBL] [Abstract][Full Text] [Related]
33. Affluence and Breast Cancer.
Lehrer S; Green S; Rosenzweig KE
Breast J; 2016 Sep; 22(5):564-7. PubMed ID: 27296617
[TBL] [Abstract][Full Text] [Related]
34. Trends in breast cancer by race and ethnicity: update 2006.
Smigal C; Jemal A; Ward E; Cokkinides V; Smith R; Howe HL; Thun M
CA Cancer J Clin; 2006; 56(3):168-83. PubMed ID: 16737949
[TBL] [Abstract][Full Text] [Related]
35. The health care experience of patients with cancer during the last year of life: Analysis of the SEER-CAHPS data set.
Halpern MT; Urato MP; Kent EE
Cancer; 2017 Jan; 123(2):336-344. PubMed ID: 27654842
[TBL] [Abstract][Full Text] [Related]
36. SEER cancer registry biospecimen research: yesterday and tomorrow.
Altekruse SF; Rosenfeld GE; Carrick DM; Pressman EJ; Schully SD; Mechanic LE; Cronin KA; Hernandez BY; Lynch CF; Cozen W; Khoury MJ; Penberthy LT
Cancer Epidemiol Biomarkers Prev; 2014 Dec; 23(12):2681-7. PubMed ID: 25472677
[TBL] [Abstract][Full Text] [Related]
37. Increasing Incidence of Liposarcoma: A Population-Based Study of National Surveillance Databases, 2001-2016.
Bock S; Hoffmann DG; Jiang Y; Chen H; Il'yasova D
Int J Environ Res Public Health; 2020 Apr; 17(8):. PubMed ID: 32326423
[TBL] [Abstract][Full Text] [Related]
38. Examining urban and rural differences in perceived timeliness of care among cancer patients: A SEER-CAHPS study.
Mollica MA; Weaver KE; McNeel TS; Kent EE
Cancer; 2018 Aug; 124(15):3257-3265. PubMed ID: 29878305
[TBL] [Abstract][Full Text] [Related]
39. Cancer treatment and survivorship statistics, 2019.
Miller KD; Nogueira L; Mariotto AB; Rowland JH; Yabroff KR; Alfano CM; Jemal A; Kramer JL; Siegel RL
CA Cancer J Clin; 2019 Sep; 69(5):363-385. PubMed ID: 31184787
[TBL] [Abstract][Full Text] [Related]
40. Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer.
Ryerson AB; Eheman CR; Altekruse SF; Ward JW; Jemal A; Sherman RL; Henley SJ; Holtzman D; Lake A; Noone AM; Anderson RN; Ma J; Ly KN; Cronin KA; Penberthy L; Kohler BA
Cancer; 2016 May; 122(9):1312-37. PubMed ID: 26959385
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
